Cagrilintide is an investigational peptide that is generating significant interest in the field of metabolic medicine, primarily as a potential treatment for obesity and related metabolic disorders. It is a long-acting synthetic analog of the naturally occurring hormone amylin.
Read More DetailsThe information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.